BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15010070)

  • 21. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
    Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
    J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term complications in survivors of advanced stage neuroblastoma.
    Laverdière C; Cheung NK; Kushner BH; Kramer K; Modak S; LaQuaglia MP; Wolden S; Ness KK; Gurney JG; Sklar CA
    Pediatr Blood Cancer; 2005 Sep; 45(3):324-32. PubMed ID: 15714447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study.
    Dimopoulos MA; Papadimitriou C; Hamilos G; Efstathiou E; Vlahos G; Rodolakis A; Aravantinos G; Kalofonos H; Kouroussis C; Gika D; Skarlos D; Bamias A
    Gynecol Oncol; 2004 Dec; 95(3):695-700. PubMed ID: 15581984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
    J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
    Akeson M; Zetterqvist BM; Dahllöf K; Brännström M; Horvath G
    Acta Obstet Gynecol Scand; 2008; 87(12):1343-52. PubMed ID: 18951208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.
    Hooning MJ; Botma A; Aleman BM; Baaijens MH; Bartelink H; Klijn JG; Taylor CW; van Leeuwen FE
    J Natl Cancer Inst; 2007 Mar; 99(5):365-75. PubMed ID: 17341728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cardiovascular morbidity in patients after treatment for testicular cancer].
    Valentová M; Mladosievicová B
    Vnitr Lek; 2010 Sep; 56(9):915-9. PubMed ID: 21137178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
    Biró K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
    Magy Onkol; 2006; 50(4):329-35. PubMed ID: 17216007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.
    Nuver J; Smit AJ; Wolffenbuttel BH; Sluiter WJ; Hoekstra HJ; Sleijfer DT; Gietema JA
    J Clin Oncol; 2005 Jun; 23(16):3718-25. PubMed ID: 15738540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of an intraperitoneal chemotherapy program implemented at the Princess Margaret Hospital for patients with epithelial ovarian carcinoma.
    Chin SN; Pinto V; Rosen B; Oza A; Dodge J; Murphy J; Mackay H
    Gynecol Oncol; 2009 Mar; 112(3):450-4. PubMed ID: 19135709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
    Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.
    Rogers PC; Olson TA; Cullen JW; Billmire DF; Marina N; Rescorla F; Davis MM; London WB; Lauer SJ; Giller RH; Cushing B; ;
    J Clin Oncol; 2004 Sep; 22(17):3563-9. PubMed ID: 15337806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis.
    von Schlippe M; Fowler CJ; Harland SJ
    Br J Cancer; 2001 Sep; 85(6):823-6. PubMed ID: 11556831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Thromboembolic complications during cisplatin-containing chemotherapy for testicular cancer: a problem in the short and possibly also the long term].
    Nuver J; Gietema JA
    Ned Tijdschr Geneeskd; 2003 Mar; 147(10):428-30. PubMed ID: 12666510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in the management of non-seminomatous germ cell tumors during the cisplatin era: a single-institution experience.
    Muramaki M; Hara I; Miyake H; Yamada Y; Kawabata G; Kamidono S
    Int J Urol; 2004 Sep; 11(9):768-73. PubMed ID: 15379942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery.
    Lee SJ; Kim BG; Lee JW; Park CS; Lee JH; Bae DS
    J Obstet Gynaecol Res; 2006 Feb; 32(1):99-106. PubMed ID: 16445534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An update on the use of intraperitoneal chemotherapy in the management of ovarian cancer.
    Markman M
    Cancer J; 2009; 15(2):105-9. PubMed ID: 19390303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
    Rose PG; Ali S; Watkins E; Thigpen JT; Deppe G; Clarke-Pearson DL; Insalaco S;
    J Clin Oncol; 2007 Jul; 25(19):2804-10. PubMed ID: 17502627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.